allicin has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, AA; Al-Regaiey, KA; Alhumaydhi, FA; Aljarbou, WA; Aljasir, M; Allemailem, KS; Almatroudi, A; Alrumaihi, F; Alsahli, MA; Alsugoor, MH; AlSuhaymi, N; Alwashmi, ASS; Elsayed, AM; Khan, A; Mousa, AM; Soliman, KEA | 1 |
| Abdel-Daim, MM; Ahmed, AAM; Khalifa, HA; Kilany, OE | 1 |
2 other study(ies) available for allicin and Cardiotoxicity
| Article | Year |
|---|---|
Could allicin alleviate trastuzumab-induced cardiotoxicity in a rat model through antioxidant, anti-inflammatory, and antihyperlipidemic properties?
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiotoxicity; Rats; Trastuzumab; Tumor Necrosis Factor-alpha | 2022 |
Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Cytokines; Disulfides; Dose-Response Relationship, Drug; Doxorubicin; Inflammation; Male; Malondialdehyde; Mice; Nitric Oxide; Oxidative Stress; Sulfinic Acids | 2017 |